New combination improves radiation therapy ou

<p>A new Phase Ib/II study from researchers at <a href="https://www.mdanderson.org/">The University of Texas MD&nbsp;Anderson Cancer Center</a> and <a href="https://www.moffitt.org/">Moffitt Cancer Center</a> found that combining sensitizing drugs with a specific form of radiation therapy may be more effective in patients with locally advanced <a href="https://www.mdanderson.org/cancer-types/pancreatic-cancer.html">pancreatic cancer</a>, yielding a higher progression-free survival (PFS) and overall response rate (ORR).</p>

Related Keywords

Houston ,Texas ,United States ,University Of Texas ,Sarah Hoffe ,Cullen Taniguchi ,American Society For Radiation Oncology ,Anderson Cancer Center ,Method Of Research ,Moffitt Cancer Center ,Moffitt Cancer ,Lancet Oncology ,Radiation Oncology ,American Society ,Annual Meeting ,Body Radiation Therapy With ,Without Selective Dismutase Mimetic ,Pancreatic Adenocarcinoma ,Adaptive Randomised Placebo Controlled Phase ,